The top three myths of ‘going digital’ relate to the industry’s self-image, the perceived role of technology, and current market conditions – still, digital is not a fad and is here to stay, says industry expert.
With increasing pressures on pharma pipelines leading to greater
interest in compound licensing, firms can be caught out by failing
to give scalability issues due attention, according to Joseph
D'Antuono speaking at last week's...
Chemicals firm SAFC plans to avoid the backlash that could be on
its way as the pharma industry continues to struggle in an
ever-challenging environment, reducing its reliance on sector in a
bid to maintain its position in the market.